Search

everythinglearnresearchcommunity

for

Search:↓

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

The conclusion is that skin, mucous, and eye problems after Stevens-Johnson syndrome and Lyell syndrome significantly affect patients' lives, highlighting the need for comprehensive care and eye check-ups.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Targeted cancer therapies often cause serious skin problems that need careful management.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Cetuximab can cause eyelash growth, which is rare but manageable.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.